Earlier this morning, Bill Ackman sent a love letter to the Allergan board of directors to which Allergan, Inc. (NYSE:AGN) has responded, as exclusively reported in ValueWalk.
“We have read your recent SEC filings and published reports which state that you are negotiating a potential merger transaction with a third party, widely reported to be Actavis plc (NYSE:ACT),” the letter starts, as Ackman immediately addresses the elephant in the room: the other lover. Yesterday in Chicago Ackman seemed perturbed at the object of his desire, saying he wanted the CEO of Allergan to be fired. Today, the tone is more subdued.
Setup a free account to get access to this article (no credit card required).
Login required to continue reading.
